Bilun Gemicioğlu

Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

William W. Busse, Eugene R. Bleecker, J Mark FitzGerald et al. · The Lancet Respiratory Medicine · 2018 · 311 citations

Pharmacy, Pharmacology, Pharmacotherapy +6

Association between Obesity and Asthma

Emine Karabul, Berk Değirmenci, Ayşe Firuze Özgökçe et al. · Turkish Thoracic Journal · 2019 · 148 citations · Full text

Public Health, Immunology, Epidemiology +5

Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study

Andrew Menzies‐Gow, Michael E. Wechsler, Christopher E. Brightling et al. · The Lancet Respiratory Medicine · 2023 · 141 citations · Full text

Life Sciences, Immunology, Internal Medicine +13

Mobile technology offers novel insights into the control and treatment of allergic rhinitis: The MASK study

Annabelle Bédard, Xavier Basagaña, Josep M Antó et al. · Journal of Allergy and Clinical Immunology · 2019 · 134 citations · Full text

Life Sciences, Otolaryngology, Pharmacotherapy +15

The Allergic Rhinitis and its Impact on Asthma (ARIA) score of allergic rhinitis using mobile technology correlates with quality of life: The MASK study

Jean Bousquet, S. Arnavielhe, Anna Bedbrook et al. · Allergy · 2017 · 101 citations · Full text

Life Sciences, Health Informatics, Allergy +16